Back to search
Moderate to Severe Atopic Hand and Foot Dermatitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Moderate to Severe Atopic Hand and Foot Dermatitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Moderate to Severe Atopic Hand and Foot Dermatitis trials you may qualify forThe main purpose of this study is to assess the efficacy of lebrikizumab versus placebo on skin lesions in adults and adolescent participants with atopic hand a…
The primary objective of the study is to assess the efficacy of dupilumab on skin lesions in patients with atopic hand and foot dermatitis. The secondary objec…